Achilles Therapeutics plc (NASDAQ:ACHL – Get Rating) was the recipient of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 14,800 shares, a growth of 114.5% from the April 30th total of 6,900 shares. Approximately 0.0% of the company’s shares are sold short. Based […]
Related Keywords
, Achilles Therapeutics Plc , Forefront Analytics , Blackrock Inc , Sei Investments Co , Renaissance Technologies , Nasdaq , Millennium Management , Achilles Therapeutics Company Profile , Achilles Therapeutics , Get Rating , Chardan Capital , Sei Investments , Therapeutics Plc , Achilles Therapeutics Daily , Nasdaq Achl , Bachl , Medical , Stocks , Options , Put , Call ,
vimarsana.com © 2020. All Rights Reserved.